Sales & Marketing News | pharmaphorum

News

Man sneezes and puts hand out to viewer to keep distance

Allergy Tx plots grass pollen jab launch after German okay

Allergy Therapeutics has had its grass pollen allergy treatment Grassmuno approved in Germany, its first market, setting up a launch early next year.

News

Enhertu moves into frontline breast cancer treatment

Daiichi Sankyo and AstraZeneca's Enhertu has become the first new first-line option in the US for HER2-positive breast cancer in more than a decade.

News

Sanofi gets double blow for MS drug tolebrutinib

Shares in Sanofi have slid on a double dose of bad news for its oral BTK inhibitor tolebrutinib, in development as a therapy for multiple sclerosis.

News

GSK closes on approval of asthma hope depemokimab

GSK is poised for the first major approval of depemokimab, a long-acting drug for severe asthma that can be dosed just twice a year.

News

CHMP decision levels the playing field for GSK's RSV jab

GSK's RSV vaccine is poised for EU approval in all adults aged 18 and over, bringing it into line with rival shots from Pfizer and Moderna.

News

Raymond Chua of Singapore's Health Sciences Authority and Lawrence Tallon of the UK Medicines and Healthcare products Regulatory Agency.

UK teams up with Singapore on healthtech regulation

A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.

Allergy Tx plots grass pollen jab launch after German okay

Enhertu moves into frontline breast cancer treatment

Sanofi gets double blow for MS drug tolebrutinib

GSK closes on approval of asthma hope depemokimab

CHMP decision levels the playing field for GSK's RSV jab

UK teams up with Singapore on healthtech regulation

MSD gets first FDA okay for oral PCSK9 cholesterol drug

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks